{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:03Z","timestamp":1793332443282,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.avsg.2023.11.061","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T16:25:30Z","timestamp":1712247930000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["\u201cEvolution of Drug-Coated Devices for the Treatment of Chronic Limb Threatening Ischemia\u201d"],"prefix":"10.1016","volume":"107","author":[{"given":"Thomas","family":"Creeden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8829-2831","authenticated-orcid":false,"given":"Douglas W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2023.11.061_bib1","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2023.11.061_bib2","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"Bradbury","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2023.11.061_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13063-017-1968-6","article-title":"BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial","volume":"18","author":"Hunt","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.avsg.2023.11.061_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.avsg.2023.11.061_bib5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2023.11.061_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2023.11.061_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2023.11.061_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2023.11.061_bib9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2023.11.061_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2023.11.061_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2023.11.061_bib12","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2023.11.061_bib13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2023.11.061_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the IMPERIAL randomized study of the Eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent","volume":"44","author":"Muller-Hulsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jcin.2018.01.233","article-title":"Public health impact of the centers for medicare and medicaid services decision on pass-through add-on payments for drug-coated balloons: a call to action","volume":"11","author":"Shishehbor","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2023.11.061_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jvs.2019.05.002","article-title":"Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease","volume":"70","author":"Mills","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.11.061_bib17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1526602820921555","article-title":"New innovations and devices in the management of chronic limb-threatening ischemia","volume":"27","author":"Kim","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2023.11.061_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib19","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jacc.2019.02.020","article-title":"Drug-eluting stent implantation and long-term survival following peripheral artery revascularization","volume":"73","author":"Secemsky","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib20","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jacc.2021.08.052","article-title":"Safety and effectiveness of paclitaxel drug-coated devices in peripheral artery revascularization: insights from VOYAGER PAD","volume":"78","author":"Hess","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib21","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2023.11.061_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamainternmed.2021.2738","article-title":"Longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among medicare beneficiaries: the SAFE-PAD study","volume":"181","author":"Secemsky","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.avsg.2023.11.061_bib23","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(23)02189-X","article-title":"Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis","volume":"402","author":"Parikh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2023.11.061_bib24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jvs.2010.01.083","article-title":"Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia","volume":"51","author":"Simons","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.11.061_bib25","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jvs.2009.09.044","article-title":"Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia","volume":"50","author":"Conte","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.11.061_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1067\/mva.2003.125","article-title":"A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases","volume":"37","author":"Pomposelli","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.11.061_bib27","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib28","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jcin.2015.07.011","volume":"8","author":"Zeller","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2023.11.061_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.2021204294","article-title":"Randomized controlled trial comparing drug-coated balloon angioplasty versus conventional balloon angioplasty for treating below-the-knee arteries in critical limb ischemia: the SINGA-PACLI trial","volume":"300","author":"Patel","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.avsg.2023.11.061_bib30","first-page":"205","article-title":"Drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: six-month results of the Lutonix BTK trial","volume":"31","author":"Mustapha","year":"2019","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1526602815592206","article-title":"An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"22","author":"Committee","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2023.11.061_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/1526602820931559","article-title":"Safety and efficacy of drug-coated balloon angioplasty for the treatment of chronic limb-threatening ischemia: a systematic review and meta-analysis","volume":"27","author":"Giannopoulos","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2023.11.061_bib33","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jvs.2023.01.195","article-title":"Outcome after revascularization with paclitaxel-coated devices in patients with chronic limb-threatening ischemia","volume":"77","author":"Smith","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.11.061_bib34","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jvs.2021.05.035","article-title":"Paclitaxel-coated peripheral arterial devices are associated with improved overall survival and limb salvage in patients with chronic limb-threatening ischemia","volume":"74","author":"Kumins","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.11.061_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","article-title":"Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease","volume":"55","author":"Bosiers","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.11.061_bib37","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2014.04.015","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial","volume":"7","author":"Siablis","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2023.11.061_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002376","article-title":"Percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia (PADI) trial","volume":"9","author":"Spreen","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2023.11.061_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1358863X231199489","article-title":"Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries","volume":"28","author":"van Overhagen","year":"2023","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2023.11.061_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.23736\/S0392-9590.19.04049-5","article-title":"The use of drug-eluting stents in infrapopliteal arteries: an updated systematic review and meta-analysis of randomized trials","volume":"38","author":"Varcoe","year":"2019","journal-title":"Int Angiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.carrev.2022.03.035","article-title":"12-Months results from the PRESTIGE study using sirolimus drug-eluting balloons in the treatment of complex BTK tibial atherosclerotic lesions in CLTI patients","volume":"43","author":"Tang","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.avsg.2023.11.061_bib43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00270-008-9472-8","article-title":"AMS INSIGHT--absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis","volume":"32","author":"Bosiers","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2023.11.061_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2305637","article-title":"Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease","volume":"390","author":"Varcoe","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089050962400147X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089050962400147X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:16:58Z","timestamp":1724797018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089050962400147X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":44,"alternative-id":["S089050962400147X"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2023.11.061","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cEvolution of Drug-Coated Devices for the Treatment of Chronic Limb Threatening Ischemia\u201d","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2023.11.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}